(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
Aug 20 (Reuters) - European shares rose for the third
straight session on Tuesday, building on a recovery since late
last week as British drugmaker AstraZeneca surged on results of
a late-stage study.
Shares of the drugmaker AZN.L rose 1.5% after the company
said its diabetes drug Farxiga met the main goal of the study
for the treatment of patients with heart failure. The pan-European STOXX 600 index .STOXX was up 0.1% by
0712 GMT, with London's FTSE 100 .FTSE outperforming.
Pandora A/S PNDORA.CO jumped 6.4% to the top of the STOXX
600 index on Tuesday after the Danish jewellery maker maintained
its full-year guidance. However, a fall in bank shares .SX7P and auto parts makers
.SXAP capped gains.